130 related articles for article (PubMed ID: 30941972)
21. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
[TBL] [Abstract][Full Text] [Related]
22. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
23. Detection of transforming growth factor-alpha in the serum of gastric carcinoma patients.
Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi SY; Shim KS; Han WS
Oncology; 1999 Oct; 57(3):236-41. PubMed ID: 10545793
[TBL] [Abstract][Full Text] [Related]
24. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract][Full Text] [Related]
25. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of early postoperative tumor marker response in gastric cancer.
Nam DH; Lee YK; Park JC; Lee H; Shin SK; Lee SK; Lee YC; Cheong JH; Hyung WJ; Noh SH; Kim CB
Ann Surg Oncol; 2013 Nov; 20(12):3905-11. PubMed ID: 23807661
[TBL] [Abstract][Full Text] [Related]
29. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
31. Serum interleukin-6 and -10 levels in patients with gastric cancer.
Ikeguchi M; Hatada T; Yamamoto M; Miyake T; Matsunaga T; Fukumoto Y; Yamada Y; Fukuda K; Saito H; Tatebe S
Gastric Cancer; 2009; 12(2):95-100. PubMed ID: 19562463
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
Gaspar MJ; Arribas I; Coca MC; Díez-Alonso M
Tumour Biol; 2001; 22(5):318-22. PubMed ID: 11553862
[TBL] [Abstract][Full Text] [Related]
33. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Murakami S; Satomi A; Ishida K; Murai H; Matsuki M; Hashimoto T
Cancer; 1994 Nov; 74(10):2745-8. PubMed ID: 7525035
[TBL] [Abstract][Full Text] [Related]
34. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D
Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430
[TBL] [Abstract][Full Text] [Related]
35. The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases.
Wada N; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Surg Today; 2017 Feb; 47(2):227-232. PubMed ID: 27566604
[TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum levels of interleukin-37 correlate with poor prognosis in gastric cancer.
Zhang Y; Tang M; Wang XG; Gu JH; Zhou LN; Jin J; Li P; Wang LQ; Chen MB
Rev Esp Enferm Dig; 2019 Dec; 111(12):941-945. PubMed ID: 31718212
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of tumor-associated antigen (2H6 antigen) in detecting early stages of gastric cancer.
Harada H; Tsukada Y; Karasawa Y
Clin Chim Acta; 1994 Aug; 228(2):101-12. PubMed ID: 7527311
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance and usefulness of soluble heparin binding-epidermal growth factor in gastric cancer.
Chung HW; Kong HY; Lim JB
World J Gastroenterol; 2015 Feb; 21(7):2080-8. PubMed ID: 25717241
[TBL] [Abstract][Full Text] [Related]
40. Clinical value of combined tests for tumor markers for gastric cancer.
Xu MX; Cui HJ; Yao TL; Gui YF
J Biol Regul Homeost Agents; 2018; 32(2):263-268. PubMed ID: 29685004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]